Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
4.290
+0.050 (1.18%)
Oct 29, 2025, 9:42 AM EDT - Market open
CDIO Revenue
Cardio Diagnostics Holdings had revenue of $7.48K in the quarter ending June 30, 2025, a decrease of -5.02%. This brings the company's revenue in the last twelve months to $19.51K, down -50.16% year-over-year. In the year 2024, Cardio Diagnostics Holdings had annual revenue of $34.89K with 104.45% growth.
Revenue (ttm)
$19.51K
Revenue Growth
-50.16%
P/S Ratio
383.23
Revenue / Employee
$1,300
Employees
15
Market Cap
7.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.89K | 17.83K | 104.45% |
| Dec 31, 2023 | 17.07K | 16.12K | 1,696.32% |
| Dec 31, 2022 | 950.00 | 49.00 | 5.44% |
| Dec 31, 2021 | 901.00 | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
CDIO News
- 1 day ago - Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee Community - Business Wire
- 8 days ago - Cardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United States - Business Wire
- 3 months ago - Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Business Wire
- 4 months ago - Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease - Business Wire
- 5 months ago - Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology - Business Wire
- 5 months ago - Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price - Business Wire
- 5 months ago - Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico - Business Wire
- 6 months ago - Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split - Business Wire